TSX-V:PCLO • CA71716K1012
The current stock price of PCLO.CA is 0.065 CAD. Today PCLO.CA is up by 18.18%. In the past month the price decreased by -18.75%. In the past year, price decreased by -51.85%.
ChartMill assigns a technical rating of 2 / 10 to PCLO.CA. When comparing the yearly performance of all stocks, PCLO.CA is a bad performer in the overall market: 92.89% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to PCLO.CA. Both the profitability and financial health of PCLO.CA have multiple concerns.
Over the last trailing twelve months PCLO.CA reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS increased by 57.3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -74.31% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.23 | 2.687B | ||
| CRON | CRONOS GROUP INC | 39.13 | 1.3B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.162B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 7.29 | 918.667M | ||
| DHT-U | DRI HEALTHCARE TRUST | 5.1 | 642.517M | ||
| GUD | KNIGHT THERAPEUTICS INC | 129.23 | 612.126M | ||
| WEED | CANOPY GROWTH CORP | N/A | 590.015M | ||
| NGEN | NERVGEN PHARMA CORP | N/A | 451.829M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 18.16 | 374.397M | ||
| TSND | TERRASCEND CORP | N/A | 345.979M | ||
| HITI | HIGH TIDE INC | 24.27 | 294.431M | ||
| ACB | AURORA CANNABIS INC | 59.28 | 271.641M | ||
| OGI | ORGANIGRAM GLOBAL INC | 28.75 | 264.855M |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The firm has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade dried cannabis flower, cannabis oil extracts and cannabis-related products sold in bulk to pharmaceutical companies and medicinal cannabis distributors globally. In Colombia, PharmaCielo Colombia is a fully licensed cultivator, producer, and distributor of both TetraHydroCannabinol and Cannabidiol medical cannabis. Ubiquo is a knowledge management and medical consultation system. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate.
IPO: 2018-01-30
PHARMACIELO LTD
82 Richmond Street East
TORONTO ONTARIO M5C 2V6 CA
CEO: David Attard
Employees: 49
Phone: 14163158741.0
PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The firm has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade dried cannabis flower, cannabis oil extracts and cannabis-related products sold in bulk to pharmaceutical companies and medicinal cannabis distributors globally. In Colombia, PharmaCielo Colombia is a fully licensed cultivator, producer, and distributor of both TetraHydroCannabinol and Cannabidiol medical cannabis. Ubiquo is a knowledge management and medical consultation system. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate.
The current stock price of PCLO.CA is 0.065 CAD. The price increased by 18.18% in the last trading session.
PCLO.CA does not pay a dividend.
PCLO.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
PHARMACIELO LTD (PCLO.CA) operates in the Health Care sector and the Pharmaceuticals industry.
PHARMACIELO LTD (PCLO.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.04).
PHARMACIELO LTD (PCLO.CA) has a market capitalization of 12.21M CAD. This makes PCLO.CA a Nano Cap stock.